966
Views
19
CrossRef citations to date
0
Altmetric
Clinical Study

High serum chemerin level in CKD patients is related to kidney function, but not to its adipose tissue overproduction

, , , , , & show all
Pages 1033-1038 | Received 28 Jan 2015, Accepted 29 Mar 2015, Published online: 06 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hamid Nomani, Hamid Khanmohamadian, Asad Vaisi-Raygani, Ebrahim Shakiba, Maryam Tanhapour & Zohreh Rahimi. (2018) Chemerin rs17173608 and vaspin rs2236242 gene variants on the risk of end stage renal disease (ESRD) and correlation with plasma malondialdehyde (MDA) level. Renal Failure 40:1, pages 350-356.
Read now

Articles from other publishers (18)

Zhiyun Zang, XiaoFang Wu, Dengyan Ma, Xiaoxiao Xia, Xueqin He, Xiaolei Chen & Zi Li. (2023) The Association between Serum Chemerin and Peritoneal Membrane Transport Function in Patients Undergoing Incident Peritoneal Dialysis: A Prospective Cohort Study. Blood Purification, pages 1-10.
Crossref
Amir Hossein Behnoush, Parnian Shobeiri, Pegah Bahiraie, Nikan Amirkhani, Amirmohammad Khalaji & Soheil Peiman. (2023) Chemerin levels in chronic kidney disease: A systematic review and meta-analysis. Frontiers in Endocrinology 14.
Crossref
Faiez Zannad, João Pedro Ferreira, Javed Butler, Gerasimos Filippatos, James L Januzzi, Mikhail Sumin, Matthias Zwick, Maral Saadati, Stuart J Pocock, Naveed Sattar, Stefan D Anker & Milton Packer. (2022) Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme. European Heart Journal 43:48, pages 4991-5002.
Crossref
Cornelia Then, Christian Herder, Barbara Thorand, Chaterina Sujana, Margit Heier, Christa Meisinger, Annette Peters, Wolfgang Koenig, Wolfgang Rathmann, Michael Roden, Michael Stumvoll, Haifa Maalmi, Holger Then, Uta Ferrari, Jürgen Scherberich & Jochen Seissler. (2022) Association of serum uromodulin with adipokines in dependence of type 2 diabetes. Cytokine 150, pages 155786.
Crossref
Ahmad El Askary, Amal F. Gharib, Mazen Almehmadi, Maha Mahfouz Bakhuraysah, Abdulaziz Ali Al Hajjiahmed, Layla Ibrahim Al-Hejji, Mohammed S. Alharthi & Alaa Shafie. (2021) The role of vitamin D deficiency and elevated inflammatory biomarkers as risk factors for the progression of diabetic nephropathy in patients with type 2 diabetes mellitus. Open Chemistry 19:1, pages 1174-1183.
Crossref
Ke Zhao, Wenyu Ding, Yong Zhang, Kaihui Ma, Dong Wang, Chunhua Hu, Junjun Liu & Xiandang Zhang. (2020) Variants in the RARRES2 gene are associated with serum chemerin and increase the risk of diabetic kidney disease in type 2 diabetes. International Journal of Biological Macromolecules 165, pages 1574-1580.
Crossref
David J Ferland, Adam E Mullick & Stephanie W Watts. (2020) Chemerin as a Driver of Hypertension: A Consideration. American Journal of Hypertension 33:11, pages 975-986.
Crossref
Alexander Mocker, Karl F. Hilgers, Nada Cordasic, Rainer Wachtveitl, Carlos Menendez-Castro, Joachim Woelfle, Andrea Hartner & Fabian B. Fahlbusch. (2019) Renal Chemerin Expression is Induced in Models of Hypertensive Nephropathy and Glomerulonephritis and Correlates with Markers of Inflammation and Fibrosis. International Journal of Molecular Sciences 20:24, pages 6240.
Crossref
M. Carracedo, A. Witasp, A. R. Qureshi, A. Laguna‐Fernandez, T. Brismar, P. Stenvinkel & M. Bäck. (2019) Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease. Journal of Internal Medicine 286:4, pages 449-457.
Crossref
Sergio Dellepiane, Davide Medica, Cesare Guarena, Tiziana Musso, Alessandro Domenico Quercia, Gianluca Leonardi, Marita Marengo, Massimiliano Migliori, Vincenzo Panichi, Luigi Biancone, Francesco Pizzarelli, Giovanni Camussi & Vincenzo Cantaluppi. (2019) Citrate anion improves chronic dialysis efficacy, reduces systemic inflammation and prevents Chemerin-mediated microvascular injury. Scientific Reports 9:1.
Crossref
Stephanie W. Watts, Emma S. Darios, Adam E. Mullick, Hannah Garver, Thomas L. Saunders, Elizabeth D. Hughes, Wanda E. Filipiak, Michael G. Zeidler, Nichole McMullen, Christopher J. Sinal, Ramya K. Kumar, David J. Ferland & Gregory D. Fink. (2018) The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension. The FASEB Journal 32:12, pages 6596-6614.
Crossref
Paul Horn, Christian von Loeffelholz, Franziska Forkert, Sven Stengel, Philipp Reuken, René Aschenbach, Andreas Stallmach & Tony Bruns. (2018) Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis. Scientific Reports 8:1.
Crossref
Stephanie Zylla, Rainer Rettig, Henry Völzke, Karlhans Endlich, Matthias Nauck & Nele Friedrich. (2018) Serum chemerin levels are inversely associated with renal function in a general population. Clinical Endocrinology 88:1, pages 146-153.
Crossref
Trujillo Joyce, Yolanda Irasema Chirino, Martínez-Tagüeña Natalia & Pedraza-Chaverri Jose. (2018) Renal damage in the metabolic syndrome (MetSx): Disorders implicated. European Journal of Pharmacology 818, pages 554-568.
Crossref
Noushin Azadpour, Bakhtyar TartibianŞükran Nazan Koşar. (2017) Effects of aerobic exercise training on ACE and ADRB2 gene expression, plasma angiotensin II level, and flow-mediated dilation: a study on obese postmenopausal women with prehypertension. Menopause 24:3, pages 269-277.
Crossref
Paul Horn, Uta Barbara Metzing, Ricardo Steidl, Bernd Romeike, Falk Rauchfuß, Christoph Sponholz, Daniel Thomas-Rüddel, Katrin Ludewig, Andreas L. Birkenfeld, Utz Settmacher, Michael Bauer, Ralf Alexander Claus & Christian von Loeffelholz. (2016) Chemerin in peritoneal sepsis and its associations with glucose metabolism and prognosis: a translational cross-sectional study. Critical Care 20:1.
Crossref
Mario Bonomini & Assunta Pandolfi. (2016) Chemerin in renal dysfunction and cardiovascular disease. Vascular Pharmacology 77, pages 28-34.
Crossref
Shuhua LinJian TengJixia LiFang SunDong YuanJing Chang. (2016) Association of Chemerin and Vascular Endothelial Growth Factor (VEGF) with Diabetic Nephropathy. Medical Science Monitor 22, pages 3209-3214.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.